Vicore Pharma Revenue

Pharmaceutical Manufacturing • Kornhamnstorg 53, Stockholm, Sweden • 21-50 Employees

Vicore Pharma revenue & valuation

Annual revenue	$508,000
Revenue per employee	$11,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,700,000
Total funding	$56,200,000

Key Contacts at Vicore Pharma

Ahmed Mousa

Chief Executive Officer

Ann Barbier

Member Board Of Directors

Karin Eklund Vanderpol

Senior Director Regulatory Affairs

Katrine Husum

Senior Project Director

May-Lill Garly

Global Medical Director

Anne Katrine Cohrt

Sr. Director, Head Of Clinical Operations

Jennifer Medong

It Director

Johanna Grans

Program Director - Early Development

Sandra Undefined

Creative Director

Company overview

Headquarters	Kornhamnstorg 53, Stockholm, Stockholm County 111 27, SE
Phone number	+46317880560
Website	vicorepharma.com
NAICS	3254
SIC	283
Keywords	Pharmaceutical Development
Founded	2009
Employees	21-50
Socials

Vicore Pharma Email Formats

Vicore Pharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@vicorepharma.com), used 55.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@vicorepharma.com	55.6%
{first name}.{last name}	john.doe@vicorepharma.com	44.4%

About Vicore Pharma

Vicore is an innovative clinical-stage pharmaceutical company unlocking the potential of a new class of drugs with disease-modifying potential. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Buloxibutid (C21) is a first-in-class orally available small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. Almee™ (an investigational medical device in clinical development) is a digital therapeutic based on cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis. Almee has received Breakthrough Device Designation from the FDA, reflecting its potential to have transformative impact. Using its unique expertise in ATRAG chemistry and biology, Vicore is further fueling its pipeline with several new therapies across additional potential indications. The company’s shares (VICO) are listed on Nasdaq Stockholm’s main market. For more information, see www.vicorepharma.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

C-Suite

Director

Manager

Employees by Department

Vicore Pharma has 21 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore Vicore Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-09	14	$46,200,000
2024-10-30	14	$10,000,000

Funding Insights

$56,200,000

Total funding amount

$10,000,000

Most recent funding amount

Number of funding rounds

Vicore Pharma Tech Stack

Discover the technologies and tools that power Vicore Pharma's digital infrastructure, from frameworks to analytics platforms.

Cookie Information

Cookie compliance

Google Maps

Maps

Microsoft 365

jQuery Migrate

JavaScript libraries

jQuery

JavaScript libraries

LiteSpeed

Web servers

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

WPMU DEV Smush

WordPress plugins

Frequently asked questions

Vicore Pharma is located in Kornhamnstorg 53, Stockholm, SE.

You can reach Vicore Pharma at +46317880560.

Vicore Pharma generates an estimated annual revenue of $508,000. This revenue figure reflects the company's market position and business performance in its industry.

Vicore Pharma has an estimated valuation of $1,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Vicore Pharma was founded in 2009, making it 17 years old. The company has established itself as a significant player in its industry over this time.

Vicore Pharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Vicore Pharma has raised a total of $56,200,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.